| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ALL.12209 |
| P8608 | Fatcat ID | release_bxny3lxtqncnfbuanr75ovs72u |
| P698 | PubMed publication ID | 23919330 |
| P5875 | ResearchGate publication ID | 255688433 |
| P50 | author | Martin Metz | Q37838546 |
| Marcus Maurer | Q50039778 | ||
| P2093 | author name string | K Weller | |
| P Martus | |||
| K Krause | |||
| P Staubach | |||
| M Magerl | |||
| A Groffik | |||
| N Tohme | |||
| P2860 | cites work | Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group | Q34029593 |
| What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature | Q34113714 | ||
| Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report | Q34150295 | ||
| Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation | Q34193483 | ||
| EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria | Q35004484 | ||
| Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey | Q35268223 | ||
| The spectrum of chronic angioedema | Q37426730 | ||
| Measuring the health status burden in hemodialysis patients using the SF-36® health survey | Q37802773 | ||
| New topics in bradykinin research. | Q37920922 | ||
| Development and construct validation of the angioedema quality of life questionnaire | Q39565260 | ||
| Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity | Q39707494 | ||
| A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). | Q47776771 | ||
| Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis | Q48491865 | ||
| Chronic spontaneous urticaria: how to assess quality of life in patients receiving treatment | Q48567207 | ||
| Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial | Q48595329 | ||
| Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper | Q48949793 | ||
| Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. | Q50948117 | ||
| How to assess disease activity in patients with chronic urticaria? | Q52918756 | ||
| Quality of life questionnaires: does statistically significant = clinically important? | Q53572519 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1185-1192 | |
| P577 | publication date | 2013-08-06 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Development, validation, and initial results of the Angioedema Activity Score | |
| P478 | volume | 68 |
| Q49817942 | Angioedema in Chronic Spontaneous Urticaria Is Underdiagnosed and Has a Substantial Impact: Analyses From ASSURE-CSU. |
| Q88801238 | Chronic Urticaria: Comparisons of US, European, and Asian Guidelines |
| Q49526540 | Chronic urticaria in most patients is poorly controlled. Results of the development, validation, and real life application of the arabic urticaria control test |
| Q52661824 | Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update. |
| Q46798966 | Diagnosis and therapy of chronic urticaria-what is expected from the revision and update of the international guidelines? A report of the public consensus conference "URTICARIA 2012" |
| Q47152048 | Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema. |
| Q47783261 | Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria |
| Q38965393 | Efficacy of Treatment of Non-hereditary Angioedema |
| Q52567183 | Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: the OPUS-2 study. |
| Q58554587 | How the Smartphone Is Changing Allergy Diagnostics |
| Q35108534 | Insights and advances in chronic urticaria: a Canadian perspective |
| Q92643892 | Management of chronic urticaria in children: a clinical guideline |
| Q56983824 | Management of patients with hereditary angioedema in Germany: comparison to other countries in the Icatibant Outcome Survey |
| Q55429844 | Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies. |
| Q47731684 | Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data |
| Q26783158 | Profile of omalizumab in the treatment of chronic spontaneous urticaria |
| Q56444281 | Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria |
| Q30249123 | The Humanistic, Societal, and Pharmaco-economic Burden of Angioedema. |
| Q90734618 | Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020 |
| Q44415453 | Useful tools for documenting urticaria |
| Q64285075 | Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria |